Gain Therapeutics announces the appointment of Jonas Hannestad, M.D., Ph.D. as its chief medical officer, effective as of March 25, 2024. Previously, he served as Chief Medical Officer at Tranquis Therapeutics and Capacity Bio, SVP of Clinical Development at Alkahest, Medical Director at Denali Therapeutics, and Director of Neuroscience Discovery Medicine at UCB Pharma.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GANX:
- Gain Therapeutics Reports Financial Results for Year End 2023 and Provides Corporate Update
- Gain Therapeutics reports FY23 EPS ($1.71), consensus ($1.57)
- GANX Earnings this Week: How Will it Perform?
- Gain Therapeutics to Present at Public Ventures Discovery Day
- Gain Therapeutics presents data at AD/PD 2024 conference
